• כרטיס רופא והטבות
  • אתרי הר"י
  • צרו קשר
  • פעולות מהירות
  • עברית (HE)
  • מה תרצו למצוא?

        תוצאת חיפוש

        ספטמבר 2001

        אלון אליקים, ברוך וולך
        עמ'

        אלון אליקים, ברוך וולך

         

        (1)מרכז ספורט ובריאות לילדים ולנוער, מח' ילדים, ביה"ח מאיר, כפר-סבא, הפקולטה לרפואה סאקלר, אוניברסיטת תל-אביב, (2) מרכז ריבשטיין לרפואת ספורט ולמחקר, מכון וינגייט, נתניה

         

        פעילות גופנית תחביבנית ידועה זה שנים רבות כמקדמת בריאות, ומסייעת למניעה ולטיפול במחלות רבות. לעומת זאת, העיסוק בספורט תחרותי, במיוחד ברמות הגבוהות, כרוך באימון גופני רב ועלול להיות תובעני מאוד. יעילות האימון תלויה בעומס, במשך האימון הגופני ובתדירותו מחד-גיסא, וביכולת הספורטאי לעמוד בעומס זה מאידך-גיסא. יכולת זו מושפעת, פרט לעומס האימון, מגורמים אישיים וסביבתיים רבים, כגון מצבו הבריאותי והתזונתי של הספורטאי, תנאי הסביבה והאקלים (אקלים גבהים, מעבר אזורי זמן וכד') ומצבי דחק אישיים אחרים (יחסי בני-זוג, עבודה, מבחנים, אסון משפחתי וכד'). חוסר איזון בין עומס האימון ליכולת הספורטאי לעמוד בפניו, יובילו להתהוות תיסמונת אימון-יתר (over-training syndrome).

        אוגוסט 2001

        יהונתן שרעבי, אהוד גרוסמן
        עמ'

        יהונתן שרעבי, אהוד גרוסמן

         

        המח' לרפואה פנימית ד', מרכז רפואי שיבא, תל-השומר והפקולטה לרפואה סאקלר, אוניברסיטת תל-אביב

         

        יתר-לחץ-דם (יל"ד) היא מחלה שכיחה ושיעור נע בין 10% בקרב צעירים ועד 50% במבוגרים מעל גיל 65. על אף העדויות המוצקות בדבר התועלת בגילוי המחלה וטיפול בה, שיעורי האיבחון עדיין נמוכים אף יותר. כיום, ההנחיות לאיבחון וטיפול ביל"ד מתבססות על מדידות במרפאה, אולם ייתכן שתנאי זה תורם לקושי בהגעה לשליטה נאותה במחלה בקרב הציבור. בנוסף, בשל האופי המשתנה של לחץ הדם, ערכי לחץ הדם שנמדדו במירפאה אינם משקפים בהכרח את לחץ הדם האופייני לחולה.

        אחד האמצעים היכולים להפחית את הצורך במדידת לחץ-הדם במירפאה, הוא שימוש במכשיר מדידת לחץ-דם עצמי (לד"ע) בביתו של הנבדק. ואכן, בשנים האחרונות, אנו עדים לשימוש גובר והולך במכשירים אלו, ובמקביל – לפירסומן של עבודות אודות יעילותם של מכשירי המדידה, תקפותן של המדידות הביתיות ומשמעותן של התוצאות. עד לאחרונה, לא היו כללים ברורים לניתוח ופירוש התוצאות. השנה, התכנסה ועדה בין-לאומית, שבחנה סוגיות אלו ופירסמה הנחיות קליניות ראשוניות אודות השימוש במכשירי מדידת לחץ-דם ביתיים באיבחון וטיפול ביל"ד. בסקירה זו, נדווח על עבודות מרכזיות בנושא, נציג את ההנחיות ונמליץ על אופן יישומן בהתמודדות היומיומית עם האיבחון והטיפול ביל"ד.

        יולי 2001

        יוסי רימר, מיכאל יפה ורון שאול
        עמ'

        Menetrier's Disease in Children

         

        Yossi Rimar, Michael Jaffe, Ron Shaoul

         

        Department of Pediatrics, Bnei-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel

         

        Menetrier's disease in children is a rare disorder that is characterized by the presence of marked protein losing gastropathy associated with enlarged and thickened gastric folds. Abnormal regulation of gastric epithelial growth, probably triggered by an infectious agent, has been suggested as an etiology for this disorder. We describe a case of Menetrier's disease in a young child and review the current literature encompassing the different aspects of the disease.

        אבי בן-הרוש, בוריס קפלן, ציון בן-רפאל, דוב פלדברג
        עמ'

        אבי בן-הרוש, בוריס קפלן, ציון בן-רפאל, דוב פלדברג

         

        החטיבה למיילדות וגינקולוגיה, מרכז רפואי רבין, קמפוס ביילינסון, פתח-תקווה

         

        כעשרים שנה לאחר לידת יילוד ההפריה החוץ-גופית (הח"ג) (IVFIN Vitro Fertilization) הראשון, נולדים ברחבי העולם כ-40,000 ילודים באופן זה מדי שנה. הריונות אלה שונים מהריונות "עצמוניים", בעיקר בשיעור גבוה יותר של הריונות מרובי-עוברים (המ"ע), לאחר החזרת יותר מעובר אחד לרחם. במרבית המדינות מדווח, כי שיעור המ"ע לאחר הח"ג נמדד כדי 40%-30%, בהשוואה לשיעור של 3%-2% באוכלוסייה כללית. שיטות ההפריה החדישות (ART- Assisted Reproductive Technology), בהן מתבצעת הח"ג והחזרת מספר עוברים לרחם (ET- Embryo Transfer), יחד עם שיטות חדישות להשראת ביוץ, נחשבים לגורם המוביל לעליית שיעור לידות מרובות עוברים – עליה דווח בעשורים האחרונים. מגמה זו מעוררת דאגה רבה, לנוכח ההשלכות הרפואיות החברתיות, הכלכליות והאתיות, מאחר שנשים הנושאות ברחמן שני עוברים או יותר, נמצאות בסיכון מוגבר לסיבוכי הריון ולידה ואף ליילודים צפויים שיעורי תחלואה או תמותה גדולים יותר – הן בטווח הקצר והן בטווח הארוך (כמו פגות קיצונית ו- cerebral palsy), בהשוואה להריונות יחיד. בסקירה זו, נציג את נושא החזרת העוברים ותוצאה אפשרית של המ"ע – על היבטיו השונים.

        יוני 2000

        קרלוס גורדון, עוז צור, רחל פורס, עדנה קוט ונתן גדות
        עמ'

        Benign Paroxysmal Positional Vertigo: Diagnostic Pitfalls 


        C.R. Gordon, O. Zur, R. Furas, E. Kott, N. Gadoth

         

        Depts. of Neurology and of Physical Therapy, Meir General Hospital, Kfar Saba, and Sackler Faculty of Medicine, Tel Aviv University

         

        Benign paroxysmal positional vertigo (BPPV) is a common but often unrecognized cause of treatable vertigo. Possible causes of misdiagnosis of BPPV were studied by review of the records of 191 patients referred to our neurology clinic; 36 were identified as having BPPV not previously diagnosed. On referral the patients carried the following diagnoses: unspecified dizziness/vertigo (33%), transient ischemic attacks (28%), cervicogenic vertigo (19%), psychogenic dizziness/vertigo (11%), and others (8%).

        The paroxysmal nature of the vertigo and position-precipitating factors were not spontaneously reported by 31%. Atypical, even bizarre, symptoms including dizzy sensations were reported by 19%, and neck pain and headache were cardinal symptoms that accompanied vertigo.

        The Dix-Hallpike maneuver, which is essential for the diagnosis of BPPV, was not performed in any of the patients prior to referral. 30 (83%) experienced complete resolution of signs and symptoms after the first physical treatment session.

        We conclude that non-paroxysmal, non-positional vertigo does not rule out BPPV. Atypical and even bizarre complaints of dizziness, as well as neck pain and headache could be cardinal symptoms of BPPV. The Dix-Hallpike maneuver is mandatory in those complaining of dizziness and vertigo.

        אפריל 2000

        ד' ישורון, ח' חמוד, ד' קרן, נ' מורד וי' נשיץ
        עמ'

        Acipimox as a Secondary Hypolipidemia in Combined Hypertriglyceridemia and Hyperlipidemia

         

        D. Yeshurun, H. Hamood, N. Morad, J. Naschitz

         

        Hyperlipidemia Clinic, Dept. of Medicine A, Bnai-Zion Medical Center, and Rappaport Faculty of Medicine, Technion, Haifa

         

        32 patients with hypertriglyceridemia, excessive hypertri- glyceridemia, and combined hyperlipidemia, were treated with the nicotinic acid derivative acipimox (Olbetam). First line treatment with bezafibrate, or statins in some with combined hyperlipidemia, had failed. In 10 acipimox was discontinued due to side effects or absence of clinical response. The other 22 completed 6 months of treatment with no side effects.

        Acipimox caused a significant 54% decrease in triglyceride levels, a 23% decrease in total cholesterol, and a 12% increase in HDL-cholesterol. LDL-cholesterol was difficult to calculate because of the high triglyceride levels, so no results are presented.

        Although acipimox was much better tolerated than nicotinic acid, it also had side effects, but fewer. Acipimox can therefor be used as a second-line drug, mainly in those with combined hyperlipidemia and hypertriglyceridemia.

        דצמבר 1999

        ראובן צימליכמן
        עמ'

        Treatment of Hypertension with Losartan

         

        R. Zimlichman

         

        Dept. of Medicine and Hypertension, Wolfson Medical Center, Holon

         

        The efficacy, safety and side-effects of treatment with losartan (Ocsaar) was studied for the first time in Israel in a large group of patients with mild to moderate hypertension in several community clinics. The 421 patients (51% men) aged 30-86 years (mean 58.6) received 50 mg of losartan daily, increased when necessary to 100 mg, and/or a second antihypertensive drug was given. After 4 weeks blood pressure was normalized in 344 and after 12 weeks in 363. Side-effects were minimal and treatment was effective in all age groups.

        נובמבר 1999

        יעקב פלדמן, אירית לקסר ואברהם ירצקי
        עמ'

        Left Ventricular Outflow Tract Obstruction without Left Ventric-Ular Hypertrophy Treated with Ace Inhibitors

         

        Jacob Feldman, Irit Laxer, Abraham Yaretzky

         

        Geriatric Dept., Meir Hospital, Sapir Medical Center, Kfar Saba, and Sackler Faculty of Medicine, Tel Aviv University

         

        We describe a very unusual case of sudden, severe worsening of congestive heart failure which was caused by ACE inhibitors. Diagnosis was made by echocardiogram showing a typical picture of dynamic, left ventricular outflow tract obstruction without left ventricular hypertrophy, which disappeared on discontinuing ACE inhibitors. This phenomenon has already been described as a complication of other drugs such as nitrates, commonly used as provocative tests for latent obstructive cardiomyopathy. To our knowledge ACE inhibihave not been described as a causative factor.

        אוגוסט 1999

        חיים יוספי, ראובן ויסקופר, יהושוע לשם, יעל רב-הון, גלעד רוזנברג ואפרת ישכיל
        עמ'

        Multicenter Community-Based Trial of Amlodipine in Hypertension

         

        C. Yosefy, J.R. Viskoper, Y. Leshem, Y. Rav-Hon, G.I. Rosenberg, E. Yaskil

         

        (Representing the 39 Investigators of Project AML-IL-95-001, WHO Collaborative Center for Prevention of CV Diseases) Ben-Gurion University of the Negev, Beer Sheba; Barzilai Medical Center, Ashkelon; Hypertension Clinic, Kupat Holim Afula; Statistics Consulting Unit, Haifa University; and Promedico Ltd., Petah Tikva

         

        The safety and efficacy of Amlodipine (AML) for mild to moderate hypertension was evaluated in a "real life" setting. This open non-comparative trial included 123 men and 143 women (age 30-91 years, mean 59.4). All had sitting diastolic blood pressure (DBP) between 95 and 115 mmHg, confirmed in most by 2 baseline measurements, 2 weeks apart.

        Eligible patients were given AML 5 mg daily as add-on or monotherapy and were evaluated 4 weeks later. If DBP was then >90 mmHg, the daily dose was raised to 10 mg; those with <90 mmHg remained on 5 mg. AML was continued for 8 weeks. Other BP-lowering drugs were unchanged.

         

        Of the original 266 patients 22 (8.2%) withdrew due to adverse events (AE), and others were protocol violators, lost to follow-up or withdrew, leaving 211 available for efficacy analysis. In this major group BP was reduced from 165±15/101±4 to 139±11/83±5 after 12 weeks of AML (p<0.05). The reduction was greater in those under 70 years, from 173±12/100±5 to 142±12/80±4 (p<0.05). In those with BMI>30 kg/m², BP decreased from 165±15/101±5 to 140±12/83±5 (p<0.05).

         

        Mean change in heart rate was -1.5 bpm (p<0.05). Mean final AML dose was 5.5 mg/day. The most common AML-related AE requiring cessation of the drug was pedal edema in 2.6% of the 266 patients; in 3.7% it persisted during therapy. Other AE occurring in >1% were dizziness in 1.8%, headache 1.5%, flushing 1.1% and fatigue 1.1%.

        We conclude that AML is an effective and well-tolerated antihypertensive suitable for most hypertensive patients.

        מרץ 1999

        ולדימיר שץ וסילביו קוזקוב
        עמ'

        Reactive Increase in Blood Pressure on Immobilization, but not Hypertension, Prevents Pressure Ulcers

         

        Vladimir Shats, Silvio Kozacov

         

        Geriatric Dept., Rebecca Sieff Hospital, Safed

         

        Of 135 geriatric patients immobilized for at least 2 days, 37 (27.4%) had pressure ulcers (PU). Those without PU were the control comparison group. Gender, length of immobilization, number of blood pressure determinations and proportion with hypertension were similar in those with and without PU. Those with PU were slightly older than those in the comparison group: 75.5±8.8 and 74.7±9.6 years, respectively (p>0.05).

         

        Of 66 patients with acute ischemic stroke, reactive increase of systolic or diastolic blood pressure to 140/90 mm Hg or above following immobilization, was seen in 60.6% and 22.7% of patients, respectively, and there were PU in 12.1%. Of 17 with recurrent ischemic stroke, corresponding figures were: 41.2%, 23.5% (p>0.05), and 47.1% (p<0.01). In 7 patients with previous ischemic stroke corresponding figures were: 14.3% and 0% (p<0.01) and 100% (p<0.001). In 36 operated for fracture of the femur, corresponding figures were: 50%, 11.1% (p>0.05), and 27.8% (p>0.05). For 9 patients with severe infections, sepsis or pneumonia, the corresponding figures were: 22.2% and 0.0% (p>0.05), and 44.4% (p<0.04).

         

        The proportion of patients with reactive increase in systolic blood pressure on immobilization was lower in the PU group than in the controls, 27% vs 59.2%, (p<0.001). The corresponding figures for reactive increase in diastolic blood pressure were similar, 8.1% and 20.4%, respectively (p>0.05).

         

        The mean systolic blood pressure on immobilization was higher in the control than in the PU group, 145.4±21.7 and 130.8±14.9 mm Hg, respectively (p<0.001). The corresponding figures for the mean diastolic blood pressure were similar, 81.2±10.5 and 75.7±8.9 mm Hg, respectively (p<0.01). An increase in systolic blood pressure on immobilization reduced the risk of developing PU (p<0.05).

         

        There was no significant statistical relation between diagnosis of hypertension and proportion of patients with PU (p>0.05). Of 67 patients with hypertension, in 23.9% and 74.6% of them there was no increase in systolic or diastolic blood pressure, respectively. Statistical difference between lack of diastolic or systolic response was very significant (p<0.001).

         

        Reactive increase of blood pressure, but not hypertension, predicts reduced risk of PU on immobilization in the hospitalized elderly. Diminished reactive increase of blood pressure in response to stress of any kind may be a criterion of frailty and reduced physiological reserves. Efforts to reduce elevated blood pressure when a patient is immobilized appear irrational.

        ינואר 1999

        א' איל, א' אסיה, א' יורנגסון, ח' נגר וצ' שפירר
        עמ'

        Atypical Infantile Hypertrophic Pyloric Stenosis

         

        O. Eyal, A. Asia, U. Yorgenson, H. Nagar, Z. Schpirer

         

        Pediatric and Pediatric Surgery Depts., Dana Hospital, Tel Aviv- Sourasky Medical Center, Tel Aviv

         

        Infantile hypertrophic pyloric stenosis (IHPS) is the most common reason for nonbilious vomiting in infants. Its cause is unknown. Hypertrophy of pyloric muscle can progress after birth and reach complete gastric outlet obstruction. Usually symptoms start after the age of 3 weeks. In the past diagnosis was based on history of projectile, nonbilious vomiting and palpation of a pyloric mass. Greater awareness of IHPS and increased use of imaging modalities, mainly abdominal ultrasonography, have resulted in a change in the clinical condition at presentation. The length of illness before admission has decreased and weight loss, dehydration and metabolic abnormalities have become less common. We describe an atypical clinical manifestation of IHPS: bilious vomiting. This atypical presentation may be due to earlier diagnosis.
         

        דצמבר 1998

        סרגיי גולדשטיין, יאיר לוי ויהודה שינפלד
        עמ'

        Pulmonary Hypertension and Multi-Valvular Damage Caused by Anorectic Drugs

         

        Serge E. Goldstein, Yair Levy, Yehuda Shoenfeld

         

        Medical Dept. B and Institute for Immunological Disease Research, Chaim Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University

         

        Marked obesity is an independent risk factor for multisystem morbidity. The use of anorectic drugs is an aggressive strategy for weight reduction. It appears to be an easy way of dealing with the problem, because the patient needn't change his behavior. However, such treatment is not harmless. At the end of the 60's an outbreak of pulmonary hypertension was associated with the drug aminorex, and it was soon withdrawn from the market. 30 years later it became clear that new-generation anorectic drugs (fenfluramine, dexfenfluramine, phentermine), which were being used world-wide, lead to both pulmonary hypertension and valvular damage.

         

        We describe a woman of 70 with both these complications which developed after prolonged anorectic therapy with a fenfluramine-phentermine combination.

        ספטמבר 1998

        דוד ב' ויס, שושנה גוטשלק-סבג, צבי צוקרמן, אלחנן בר-און וצבי כהנא
        עמ'

        Follicle-Stimulating Hormone in Azoospermia in Prediction of Spermatogenic Patterns

         

        David B. Weiss, Shoshana Gottschalk-Sabag, Zvi Zukerman, Elchanan Bar-On, Zvi Kahana

         

        Kupat Holim Me'uhedet; and Dept. of Pathology and Cytology and Male Infertility Unit, Shaare Zedek Medical Center, Jerusalem; Andrology Unit, Rabin Medical Center (Beilinson Campus), Petah Tikva; and Paper Research Consultant Institute, Jerusalem

         

        Follicle-stimulating hormone (FSH) is considered to be the most important plasma hormone correlated with spermatogenesis. Elevated FSH plasma levels were shown to be associated with complete damage to testicular seminiferous tubule germinal epithelium. Recently, there have been conflicting reports with regard to the value of FSH plasma levels in predicting seminiferous tubule histology in the azoospermic patient and hence, as a guide for therapy in assisted reproduction using testicular sperm retrieval. The aim of this study was to evaluate whether FSH plasma levels can predict spermatogenic pattern in the testes of the azoospermic infertile patient. 69 infertile men with non-obstructive azoospermia and 18 with very severe oligospermia were studied. In all, plasma levels of testosterone, free testosterone, prolactin, luteinizing hormone and follicle-stimulating hormone were measured by enzyme immunoassay. In the azoospermic patients the seminiferous tubule spermatogenic pattern was determined in testicular aspirates obtained by multiple fine needle aspiration and categorized according to the most mature spermatogenic cell type in the aspirates: Sertoli cells only, spermatogenic maturation arrest or full spermatogenesis. There were no significant differences in plasma levels of any hormone measured except in very severely oligospermic and azoospermic patients. Both normal and elevated levels were detected in all, regardless of seminiferous tubule cytological pattern or plasma FSH in azoospermic patients. It is concluded that plasma levels of FSH can not be used as a predictive parameter, neither for the presence of spermatozoa nor for any other seminiferous tubule cytological pattern in azoospermic infertile men. They cannot serve as guides for selection of azoospermic men for trials of testicular sperm retrieval in assisted reproduction.

        יוני 1998

        לודויג קורנל וארתור פראנקן
        עמ'

        Mechanism of Primary Hypertension

         

        Ludwig Kornel,* Arthur V. Prancan

         

        Steroid Research Laboratory, Depts. of Internal Medicine and Biochemistry, and Dept. of Pharmacology, Rush Medical Center, Chicago and *Endocrinology-Diabetes Outpatient Clinic, Kupat Holim Klalit, Jerusalem

         

        We review various theories of the pathogenetic mechanisms of steroid-induced and essential hypertension. We investigated the possibility that a pathogenetic mechanism leading to glucocorticoid (GC)-induced hypertension or to mineralocorticoid (MC)-induced hypertension, or both, may be of critical importance in primary hypertension. We studied plasma levels of corticosterone (BK) and aldosterone (Aldo), and their concentrations in arterial and renal tissues of spontaneously hypertensive rats (SHR), a model of primary hypertension, and in the antecedent strain WKY rats as a normotensive control. Plasma levels of BK and Aldo were found to be normal and identical in SHRs and WKYs. Tissue (intracellular) levels of BK were more than double in SHRs than in WKYs. Subsequently we examined the activity of 11b-hydroxy steroid dehydrogenase (11-HSD) in both aortic and renal tissues of SHRs and WKYs. 11-HSD converts BK to the corresponding 11-keto compound, 11-dehydro-corticosterone (cpd.AK), which is inactive, in view of its inability to bind to the MC receptors (and also to the GC receptors). BK, the main glucocorticoid in the rat, as well as cortisol, have high affinity for the MC-receptor (MR). Normally BK or cortisol are present in 10²-10³ times greater concentrations than Aldo in tissues possessing MR. The enzyme 11-HSD deactivates BK (or cortisol), thus protecting MC-receptors in the MC target tissues from being activated by GC. When we examined arterial and renal tissue activities of 11-HSD in SHRs, the activity of 11-HSD was only one-third that found in the WKY rats. This explained higher levels of BK in the tissues of SHR, and suggested that decreased activity of 11-HSD is a pathogenetic factor for hypertension in SHRs.

        Thus, in a model of primary hypertension such as SHR, decreased activity of 11-HSD in the target tissues of MC appears to lead to glucocorticoid-induced mineralocorticoid hypertension.

        אלי אשכנזי וסטיבן ט' אונסטי
        עמ'

        Early Results with Threaded Spinal Cage Fusion Systems

         

        Ely Ashkenazi, Stephen T. Onesti

         

        Neurosurgery Depts. of Hadassah-University Hospital, Jerusalem and Montefiore Medical Center, New York

         

        Lumbar interbody fusion is a surgical technique used to treat symptomatic lumbar disc disease. Low back disorders are the most common of the musculoskeletal disorders causing a tremendous burden of disability. One of the causes of low back pain and radiculopathy is spinal instability, which can be treated by spinal fusion. In the past year, threaded cage systems have become available for segmental lumbar fusion for degenerative disc disease. These systems offer several biomechanical advantages over traditional lumbar fusion and instrumentation techniques, and are better tolerated.

        From December 1996 until June 1997 we operated and fused spines of 17 patients, using 2 different fusion systems (anterior and posterior approaches). We present our early results.

        הבהרה משפטית: כל נושא המופיע באתר זה נועד להשכלה בלבד ואין לראות בו ייעוץ רפואי או משפטי. אין הר"י אחראית לתוכן המתפרסם באתר זה ולכל נזק שעלול להיגרם. כל הזכויות על המידע באתר שייכות להסתדרות הרפואית בישראל. מדיניות פרטיות
        כתובתנו: ז'בוטינסקי 35 רמת גן, בניין התאומים 2 קומות 10-11, ת.ד. 3566, מיקוד 5213604. טלפון: 03-6100444, פקס: 03-5753303